Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 12, 2012, Pages 7625-7630

  Min, Jeff ^a   Lukowski, Zachary L ^a   Levine, Monica A ^a   Meyers, Craig A ^a   Beattie, Ashley R ^a   Schultz, Gregory S ^a   Samuelson, Don A ^b   Sherwood, Mark B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; MELOXICAM; MITOMYCIN; SARATIN; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN; SALIVA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CONJUNCTIVA; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; EYE REDNESS; EYE SWELLING; EYELID EDEMA; FILTERING OPERATION; GLAUCOMA; HISTOLOGY; NONHUMAN; OCULAR FIBROSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RABBIT; SURVIVAL TIME; WESTERN BLOTTING; WOUND HEALING; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FOLLOW UP; INJECTION; INTRAOCULAR PRESSURE; METHODOLOGY; PATHOLOGY;

ANIMALS; CONJUNCTIVA; DISEASE MODELS, ANIMAL; FILTERING SURGERY; FOLLOW-UP STUDIES; GLAUCOMA; INJECTIONS; INTRAOCULAR PRESSURE; POSTOPERATIVE CARE; RABBITS; RECOMBINANT PROTEINS; SALIVARY PROTEINS AND PEPTIDES; WOUND HEALING;

EID: 84872185143     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10120     Document Type: Article

References (16)

1. Burr J, Azuara-Blanco A, Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2005;9:CD004399.
2. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120: 297-300.
3. Muckley ED, Lehrer RA. Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. Optom Vis Sci. 2004;81:499-504.
4. Francis BA, Du LT, Najafi K, et al. Histopathologic features of conjunctival filtering blebs. Arch Ophthalmol. 2005;123:166-170.
5. Zhongqiu L, Van Bergen T, Van de Veire S, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009; 50:5217-5225.
6. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five year follow-up. Ophthalmology. 2002; 109:1336-1341.
7. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol. 2006; 90:175-180.
8. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2003;241:106-110.
9. Barnes CS, Krafft B, Frech M, et al. Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen. Semin Thromb Hemost. 2001;24:337-348.
10. Bonnefoy A, Romijn RA, Vandervoort PA, Van Rompaey I, Vermylen J, Hoylaerts MF. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Taemost. 2006;4: 2151-2161.
11. White TC, Berny MA, Robinson DK, et al. The leech product saratin is a potent inhibitor of platelet integrin alpha2beta1 and von Willebrand factor binding to collagen. FEBS J. 2007; 274:1481-1491.
12. Gronwald W, Bomke J, Maurer T, et al. Structure of the leech protein saratin and characterization of its binding to collagen. J Mol Biol. 2008;381:913-927.
13. Smith TP, Alshafie TA, Cruz CP, et al. Saratin, an inhibitor of collagen-platelet interaction, decreases venous anastomotic intimal hyperplasia in a canine dialysis access model. Vasc Endovascular Surg. 2003;37:259-269.
14. Davis JA, Brown AT, Alshafie T, et al. Saratin (an inhibitor of platelet-collagen interaction) decreases platelet aggregation and homocysteine-mediated postcarotid endarterectomy inti-mal hyperplasia in a dose-dependent manner. Am J Surg. 2004;188:778-785.
15. Vilahur G, Duran X, Juan-Babot O, Casani L, Badimon L. Antithrombotic effects of saratin on human atherosclerotic plaques. Thromb Haemost. 2004;95:191-200.
16. Min J, Lukowski ZL, Levine MA, et al. Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator Saratin in a rabbit model. PloS One. 2012;7:e35627.